Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations.
暂无分享,去创建一个
Y. Xi | T. Yokoo | A. Singal | D. Fetzer | T. Browning | David T. Fetzer
[1] Ranjit S. Chima,et al. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) Visualization Score: a reliability analysis on inter-reader agreement , 2021, Abdominal Radiology.
[2] J. Marrero,et al. International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma. , 2021, Gastroenterology.
[3] E. Tapper,et al. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] J. Byun,et al. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma. , 2019, Radiology.
[5] M. O'Boyle,et al. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at 1 Year. , 2019, Journal of the American College of Radiology : JACR.
[6] M. O'Boyle,et al. Role of US LI-RADS in the LI-RADS Algorithm. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.
[7] Yu Shen,et al. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] M. Abecassis,et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.
[9] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[10] J. Marrero,et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. , 2018, Gastroenterology.
[11] Jasmin A. Tiro,et al. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis , 2017, Hepatology.
[12] J. Marrero,et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis , 2017, Alimentary pharmacology & therapeutics.
[13] M. Zoli,et al. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[14] Amit G. Singal,et al. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis , 2014, PLoS medicine.
[15] William M. Lee,et al. Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail? , 2013, The American Journal of Gastroenterology.
[16] K. Maturen,et al. US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma , 2017, Abdominal Radiology.